Bacterial ghosts: Non-living candidate vaccines

Journal of Biotechnology

Volumn 44, Issue 1-3, 1996, Pages 161-170

  Szostak, Michael P ^a   Hensel, Andreas ^a   Eko, Francis O ^a   Klein, Reinhard ^a   Auer, Tatjana ^a   Mader, Horst ^a   Haslberger, Alexander ^a   Bunka, Sebastian ^b   Wanner, Gerhard ^c   Lubitz, Werner ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adjuvant; Bacterial ghost; Biosafety; Carrier system; Genetic inactivation; Multi vaccine

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; CELL MEMBRANES; CLONING; COLIFORM BACTERIA; LIVING SYSTEMS STUDIES; PROTEINS;

ADJUVANTS; BACTERIAL GHOSTS; BIOSAFETY; CARRIER SYSTEM; CELLULAR IMMUNE RESPONSE; GENETIC INACTIVATION; GRAM NEGATIVE BACTERIA; HUMORAL IMMUNE RESPONSE; IMMUNOGENS;

VACCINES;

ADJUVANT; BACTERIAL VACCINE; OUTER MEMBRANE PROTEIN;

BACTERIAL MEMBRANE; BACTERIOPHAGE PHI X 174; CONFERENCE PAPER; CYTOLYSIS; HUMAN; IMMUNITY; PRIORITY JOURNAL; ULTRASTRUCTURE; VACCINATION;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALIA; BACTERIA (MICROORGANISMS); BACTERIOPHAGE PHI; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA; SALMONELLA TYPHIMURIUM; SUS SCROFA; TYPHIMURIUM; VIBRIO CHOLERAE;

EID: 0030064362     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-1656(95)00123-9     Document Type: Conference Paper

References (33)

1. Easmon, C.S.F. (1990) Laboratory diagnosis of bacterial diseases. In: Topley and Wilson (Eds.), Principles of Bacteriology, Virology and Immunity, Vol. 3: Bacterial Diseases. Hodder and Stoughton, London.
2. Bläsi, U., Henrich, B. and Lubitz, W. (1985) Lysis of Escherichia coli by cloned PhiX174 gene E depends on its expression. J. Gen. Microbiol. 131, 1107-1114.
3. Eko, F.O., Szostak, M.P., Wanner, G. and Lubitz, W. (1994a) Production of Vibrio cholerae ghosts (VCG) by expression of a cloned phage lysis gene: potential for vaccine development. Vaccine 12, 1231-1237.
4. Eko, F.O., Hensel, A., Bunka, S. and Lubitz, W. (1994b) Immunogenicity of Vibrio cholerae ghosts following intraperitoneal immunization of mice. Vaccine 12, 1330-1334.
5. Ferguson, M., Wood, D.J. and Minor, P.D. (1993) Antigenic structure of poliovirus in inactivated vaccines. J. Gen. Virol. 74, 685-690.
6. Frosch, M. and Meyer, T.F. (1992) Transformation-mediated exchange of virulence determinants by co-cultivation of pathogenic Neisseriae. FEMS Microbiol. Lett. 100, 345-350.
7. Halfmann, G., Goetz, F. and Lubitz, W. (1993) Expression of bacteriophage PhiX174 lysis gene E in Staphylococcus carnosus. FEMS Microbiol. Lett. 108, 139-43.
8. Harkness, R.E. and Lubitz, W. (1987) Construction and properties of a chimeric bacteriophages. FEMS Microbiol. Lett. 48, 19-24.
9. Henrich, B., Lubitz, W. and Plapp, R. (1982) Lysis of Escherichia coli by induction of cloned PhiX174 genes. Mol. Gen. Genet. 185, 493-497.
10. Henrich, B., Lubitz, W. and Plapp, R. (1983) Expression of PhiX174 lysis gene E cloned into different plasmids. In: Hakenbeck, R., Höltje, J.-V. and Labischinski, H. (Eds.), The Target of Penicillin. de Gruyters, Berlin, pp. 197-203.
11. Hensel, A., van Leengoed, L.M.A.G., Szostak, M., Windt, H., Weissenböck, H., Stockhofe-Zurwieden, N., Katinger, A., Stadler, M., Ganter, M., Bunka, S., Pabst, R. and Lubitz, W. (1996) Induction of protective immunity by aerosol or oral application of candidate vaccines in a dose-controlled pig aerosol infection model. J. Biotechnol. 44, 171-181.
12. Holt, M.E., Enright, M.R. and Alexander, T.J. (1990) Immunisation of pigs with killed cultures of Streptococcus suis type 2. Res. Vet. Sci. 48, 23-27.
13. Lubitz, W. and Szostak, M. (1991) Carrier-bound recombinant proteins, process for the production and use as immunogens and vaccines. European Patent No. EP 0516655 B1.
14. Lubitz, W. (1992) Process for the release of poly(3-hydroxycarboxylic-acids). US Patent 5149644.
15. MacGhee, J.R., Mestecky, J., Dertzbaugh, M.T., Eldridge, J.H., Hirasawa, M. and Kiyono, H. (1992) The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10, 75-88.
16. Maratea, D., Young, K. and Young, R. (1985) Deletion and fusion analysis of the phage Phi X174 lysis gene E. Gene 40, 39-46.
17. Melamed, D., Leitner, G. and Heller, E.D. (1991) A vaccine against avian colibacillosis based on ultrasonic inactivation of Escherichia coli. Avian Dis. 35, 17-22.
18. Miller, I.H. and Reznikoff, W.S. (1980) The Operon, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
19. Misfeldt, M.L. and Johnson, W. (1979) Identification of protective cell surface proteins in ribosomal fractions from Salmonella typhimurium: Infect. Immun. 24, 806-816.
20. Miyamea, T. (1986) Protective effects of nasal immunization in mice with various kinds of inactivated Sendai virus vaccines. Microbiol. Immunol. 30, 213-23.
21. Nair, M.P.N., Pottathil, R., Heimer, E.P. and Schwartz, S.A. (1988) Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: Effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes. Proc. Natl. Acad. Sci. USA 85, 6498-6502.
22. Nencioni, L., Pizza, M., Bugnoli, M., De Magistris, T., Di Tommaso, A., Giovannoni, F., Manetti, R., Marsili, I., Matteucci, G., Nucci, D. et al. (1991) Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough. Infect. Immun. 59, 625-630.
23. Remaut, E., Stanssens, P. and Fiers, W. (1981) Plasmid vectors for high-efficiency expression controlled by the PL promoter of coliphage lambda. Gene 15, 81-93.
24. Schlecht, S. and Bhatnagar, N. (1985) Proteins from Salmonella R-mutants mediating protection against Salmonella infection in mice. II. Protection tests performed with proteins free from lipopolysaccharide. Zentralbl. Bakteriol. Hyg. 1. Abt. Orig. A. 259, 367-377.
25. Szostak, M., G. Wanner and W. Lubitz. (1990) Recombinant bacterial ghosts as vaccines. Res. Microbiol. 141, 1005-1007.
26. Szostak, M. and Lubitz, W. (1991) Recombinant bacterial ghosts as multivaccine vehicles. In: Chanock, R.M., et al. (Eds.), Vaccines 91: Modern Approaches to New Vaccines Including Prevention of AIDS, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 409-414.
27. Szostak, M., Auer, T. and Lubitz, W. (1993) Immune response against recombinant bacterial ghosts carrying HIV-1 reverse transcriptase. In: Chanock, R.M., et al. (Eds.), Vaccines 93: Modern Approaches to New Vaccines Including Prevention of AIDS, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 419-425.
28. Tedin, K., Witte, A., Reisinger, G., Lubitz, W., Bläsi, U. (1995) Evaluation of the E. coli ribosomal rrnB P1 promoter and phage-derived lysis genes for the use in a biological containment system: A concept study. J. Biotechnol. 39, 137-148.
29. Witte, A. and Lubitz, W. (1989) Biochemical characterization of PhiX174-protein-E-mediated lysis of Escherichia coli. Eur. J. Biochem. 180, 393-398.
30. Witte, A., Wanner, G., Bläsi, U., Halfmann, G., Szostak, M. and Lubitz, W. (1990) Endogenous transmembrane tunnel formation mediated by PhiX174 lysis protein E. J. Bacteriol. 172, 4109-4114.
31. Witte, A., Narendja, F., Säckl, W., Eckerstorfer, M., Szostak, M., Bläsi, U., Halfmann, G. and Lubitz, W. (1991) Multifunctional safety vector systems for DNA cloning, controlled expression of fusion genes, and simplified preparation of vector DNA and recombinant gene products. In: Issinger, O.-G., Henke, J., Kämpf, J., Driesel, A.J. (Eds.), BioTechForum, Advances in Molecular Genetics 3. Hüthig Verlag, Heidelberg, pp. 219-239.
32. Witte, A., Wanner, G., Sulzner, M. and W. Lubitz. (1992) Dynamics of PhiX174 protein E-mediated lysis of Escherichia coli. Arch. Microbiol. 157, 381-388.
33. Witte, A., Brand, E., Schrot, G. and Lubitz, W. (1993) Pathway of PhiX174 protein E mediated lysis of Escherichia coli. In: dePedro, M.A., Höltje, J.-V., and Löffelhardt, W. (Eds.), Bacterial Growth and Lysis. Plenum Press, New York, pp. 277-283.